- Home
- PPBT vs ASST Comparison
PPBT vs ASST Comparison
Compare PPBT & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- ASST
- Stock Information
- Founded
- PPBT 2010
- ASST 2020
- Country
- PPBT Israel
- ASST United States
- Employees
- PPBT N/A
- ASST N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- ASST Computer Software: Prepackaged Software
- Sector
- PPBT Health Care
- ASST Technology
- Exchange
- PPBT Nasdaq
- ASST Nasdaq
- Market Cap
- PPBT 7.1M
- ASST 7.2M
- IPO Year
- PPBT N/A
- ASST 2023
- Fundamental
- Price
- PPBT $2.73
- ASST $0.59
- Analyst Decision
- PPBT Strong Buy
- ASST
- Analyst Count
- PPBT 1
- ASST 0
- Target Price
- PPBT $33.00
- ASST N/A
- AVG Volume (30 Days)
- PPBT 16.2K
- ASST 1.7M
- Earning Date
- PPBT 05-20-2025
- ASST 05-14-2025
- Dividend Yield
- PPBT N/A
- ASST N/A
- EPS Growth
- PPBT N/A
- ASST N/A
- EPS
- PPBT N/A
- ASST N/A
- Revenue
- PPBT N/A
- ASST $633,489.00
- Revenue This Year
- PPBT N/A
- ASST N/A
- Revenue Next Year
- PPBT N/A
- ASST N/A
- P/E Ratio
- PPBT N/A
- ASST N/A
- Revenue Growth
- PPBT N/A
- ASST 128.66
- 52 Week Low
- PPBT $2.00
- ASST $0.34
- 52 Week High
- PPBT $20.60
- ASST $3.94
- Technical
- Relative Strength Index (RSI)
- PPBT 51.95
- ASST 57.18
- Support Level
- PPBT $2.67
- ASST $0.50
- Resistance Level
- PPBT $2.75
- ASST $0.61
- Average True Range (ATR)
- PPBT 0.21
- ASST 0.07
- MACD
- PPBT 0.04
- ASST 0.01
- Stochastic Oscillator
- PPBT 67.19
- ASST 91.56
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About ASST Asset Entities Inc. Class B
Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. It has three categories of services: 1) provide subscription upgrades to premium content on investment education and entertainment servers on Discord. 2) codevelop and execute influencer social media and marketing campaigns for clients. 3) design, develop and manage Discord servers for clients under "AE.360.DDM" brand.